0001209191-15-060803.txt : 20150714 0001209191-15-060803.hdr.sgml : 20150714 20150714165121 ACCESSION NUMBER: 0001209191-15-060803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150710 FILED AS OF DATE: 20150714 DATE AS OF CHANGE: 20150714 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILBERT DENISE CENTRAL INDEX KEY: 0001224892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 15987744 MAIL ADDRESS: STREET 1: 3290 WEST BAYSHORE ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-07-10 0 0001293310 KALOBIOS PHARMACEUTICALS INC KBIO 0001224892 GILBERT DENISE C/O KALOBIOS PHARMACEUTICALS, INC. 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 3.68 2015-07-10 4 A 0 5000 0.00 A 2025-07-09 Common Stock 5000 5000 D The amount of shares covered by this option was 40,000 with an exercise price of $0.46 upon date of grant but subsequently subject to a 1 for 8 reverse stock split on July 13, 2015. The option shares will vest and become exercisable ratably over 12 months of continuous service after July 10, 2015, subject to the terms of the Company's 2012 Equity Incentive Plan. /s/ Brian Savage, attorney-in-fact 2015-07-14